Clinical Trials Directory

Trials / Unknown

UnknownNCT03388320

Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease Population

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
New York Presbyterian Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a pilot study examining whether an evidence-based recovery support smartphone application, the Addiction Comprehensive Health Enhancement Support System (A-CHESS), can decrease alcohol recidivism in a previously unstudied group of patients with alcoholic liver disease (ALD).

Detailed description

A-CHESS is a smartphone application developed by the University of Wisconsin-Madison based on self-determination theory, with a previous randomized clinical trial showing that use of the app resulted in significantly fewer risky drinking days in patients leaving treatment for alcohol-use disorders. The application is downloaded to the participant's smartphone, and provides ongoing access to peer support and educational materials, monitoring of the risk of relapse, and delivery of reminders and encouragements to the patient. The application also has a survey platform to assess and reassess the participants' most recent alcohol consumption, quality of life, and experience using the application. We anticipate that use of the A-CHESS app will result in decreased drinking and improved abstinence, identifying a potential intervention to offer patients with ALD to improve their mortality, liver disease, and likelihood of liver transplant candidacy status.

Conditions

Interventions

TypeNameDescription
DEVICEA-CHESSUse of smartphone application: Addiction Comprehensive Health Enhancement Support System (A-CHESS)

Timeline

Start date
2018-04-24
Primary completion
2021-01-15
Completion
2021-12-01
First posted
2018-01-02
Last updated
2019-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03388320. Inclusion in this directory is not an endorsement.